BACKGROUND: Reduced regional cerebral blood flow (rCBF) is a well-established finding in Alzheimer's disease (AD), although fewer studies have examined the role of increased regional cerebrovascular resistance. By calculating the ratio of mean arterial pressure to rCBF, it is possible to estimate an index of regional cerebrovascular resistance (CVRi) that may be a sensitive measure of occult cerebrovascular disease. OBJECTIVE: To compare probable AD patients to mild cognitive impairment (MCI) and normal control (NC) participants on CVRi, the ratio of mean arterial pressure to rCBF. METHODS: Eighty-one participants (12 AD, 23 MCI, 46 NC) were compared on CVRi using voxel-wise analyses. Region-of-interest analyses examined correlations between subcortical CVRi and both cognition and white matter lesion (WML) volume. RESULTS: Voxel-wise analyses revealed CVRi elevation in AD relative to NCs (subcortical, medial temporal, posterior cingulate, precuneus, inferior parietal, superior temporal) and MCI (subcortical, posterior cingulate). MCI participants exhibited intermediate CVRi values within cortical and medial temporal areas. Significant CVRi clusters were larger and more widespread than those of parallel CBF analyses. Among MCI and AD participants, subcortical CVRi elevation was associated with lower Dementia Rating Scale score (r = -0.52, p = 0.001, for both thalamus and caudate), and caudate CVRi correlated with WML volume (r = 0.45, p = 0.001). CONCLUSIONS: Cortical and subcortical CVRi is elevated in AD, particularly within the caudate and thalamus, where it is associated with decreased cognitive performance and increased WMLs. Findings suggest CVRi may play a role in cognitive decline and cerebrovascular disease in MCI and AD.
BACKGROUND: Reduced regional cerebral blood flow (rCBF) is a well-established finding in Alzheimer's disease (AD), although fewer studies have examined the role of increased regional cerebrovascular resistance. By calculating the ratio of mean arterial pressure to rCBF, it is possible to estimate an index of regional cerebrovascular resistance (CVRi) that may be a sensitive measure of occult cerebrovascular disease. OBJECTIVE: To compare probable ADpatients to mild cognitive impairment (MCI) and normal control (NC) participants on CVRi, the ratio of mean arterial pressure to rCBF. METHODS: Eighty-one participants (12 AD, 23 MCI, 46 NC) were compared on CVRi using voxel-wise analyses. Region-of-interest analyses examined correlations between subcortical CVRi and both cognition and white matter lesion (WML) volume. RESULTS: Voxel-wise analyses revealed CVRi elevation in AD relative to NCs (subcortical, medial temporal, posterior cingulate, precuneus, inferior parietal, superior temporal) and MCI (subcortical, posterior cingulate). MCI participants exhibited intermediate CVRi values within cortical and medial temporal areas. Significant CVRi clusters were larger and more widespread than those of parallel CBF analyses. Among MCI and ADparticipants, subcortical CVRi elevation was associated with lower Dementia Rating Scale score (r = -0.52, p = 0.001, for both thalamus and caudate), and caudate CVRi correlated with WML volume (r = 0.45, p = 0.001). CONCLUSIONS: Cortical and subcortical CVRi is elevated in AD, particularly within the caudate and thalamus, where it is associated with decreased cognitive performance and increased WMLs. Findings suggest CVRi may play a role in cognitive decline and cerebrovascular disease in MCI and AD.
Authors: Majon Muller; Yolanda van der Graaf; Frank L Visseren; Anne L M Vlek; Willem P Th M Mali; Mirjam I Geerlings Journal: J Hypertens Date: 2010-07 Impact factor: 4.844
Authors: Thomas G Beach; Lucia I Sue; Douglas G Walker; Marwan N Sabbagh; Geidy Serrano; Brittany N Dugger; Monica Mariner; Kim Yantos; Jonette Henry-Watson; Glenn Chiarolanza; Jose A Hidalgo; Leslie Souders Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472
Authors: Daniel A Nation; Lisa Delano-Wood; Katherine J Bangen; Christina E Wierenga; Amy J Jak; Lawrence A Hansen; Douglas R Galasko; David P Salmon; Mark W Bondi Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472
Authors: Erik D Gommer; Esther G H J Martens; Pauline Aalten; Eri Shijaku; Frans R J Verhey; Werner H Mess; Inez H G B Ramakers; Jos P H Reulen Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472
Authors: Alex E Roher; Suzanne L Tyas; Chera L Maarouf; Ian D Daugs; Tyler A Kokjohn; Mark R Emmerling; Zsolt Garami; Marek Belohlavek; Marwan N Sabbagh; Lucia I Sue; Thomas G Beach Journal: Alzheimers Dement Date: 2011-03-09 Impact factor: 21.566
Authors: D A Nation; C E Wierenga; L Delano-Wood; A J Jak; D C Delis; D P Salmon; M W Bondi Journal: J Int Neuropsychol Soc Date: 2010-07-21 Impact factor: 2.892
Authors: Mark Yarchoan; Sharon X Xie; Mitchel A Kling; Jon B Toledo; David A Wolk; Edward B Lee; Vivianna Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Steven E Arnold Journal: Brain Date: 2012-11-30 Impact factor: 13.501
Authors: Francis E Cambronero; Dandan Liu; Jacquelyn E Neal; Elizabeth E Moore; Katherine A Gifford; James G Terry; Sangeeta Nair; Kimberly R Pechman; Katie E Osborn; Timothy J Hohman; Susan P Bell; J David Sweatt; Thomas J Wang; Joshua A Beckman; John Jeffrey Carr; Angela L Jefferson Journal: Neurobiol Aging Date: 2018-02-20 Impact factor: 4.673
Authors: Daniel A Nation; Emily C Edmonds; Katherine J Bangen; Lisa Delano-Wood; Blake K Scanlon; S Duke Han; Steven D Edland; David P Salmon; Douglas R Galasko; Mark W Bondi Journal: JAMA Neurol Date: 2015-05 Impact factor: 18.302
Authors: Axel Montagne; Daniel A Nation; Judy Pa; Melanie D Sweeney; Arthur W Toga; Berislav V Zlokovic Journal: Acta Neuropathol Date: 2016-04-01 Impact factor: 17.088
Authors: Melanie D Sweeney; Kassandra Kisler; Axel Montagne; Arthur W Toga; Berislav V Zlokovic Journal: Nat Neurosci Date: 2018-09-24 Impact factor: 24.884
Authors: Oliver Bracko; Brendah N Njiru; Madisen Swallow; Muhammad Ali; Mohammad Haft-Javaherian; Chris B Schaffer Journal: J Cereb Blood Flow Metab Date: 2019-09-07 Impact factor: 6.200
Authors: Esther A H Warnert; Emma C Hart; Judith E Hall; Kevin Murphy; Richard G Wise Journal: J Cereb Blood Flow Metab Date: 2015-11-20 Impact factor: 6.200
Authors: Katherine J Bangen; Denis S Smirnov; Lisa Delano-Wood; Christina E Wierenga; Mark W Bondi; David P Salmon; Douglas Galasko Journal: Alzheimers Res Ther Date: 2021-07-01 Impact factor: 6.982